Icure Pharmaceutical Incorporation (175250) — Cash Flow Quality Index
Icure Pharmaceutical Incorporation (175250) has a Cash Flow Quality Index of -689.55x as of December 2024. Operating cash flow of ₩-17.05 Billion is below net income of ₩24.73 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 175250 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Icure Pharmaceutical Incorporation Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for Icure Pharmaceutical Incorporation across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 175250 operating cash flow.
Annual Cash Flow Quality Index for Icure Pharmaceutical Incorporation (2017–2024)
Year-by-year earnings quality comparison for Icure Pharmaceutical Incorporation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -689.55x | ₩-17.05 Billion | ₩24.73 Million | ▼ -33240.2% |
| 2017 | 2.08x | ₩1.12 Billion | ₩537.95 Million | — |